文献速递慢性肾脏病水电解质与酸碱

盐与蛋白摄入对V2RA治疗ADPKD患者多尿的影响

Effects of salt and protein intake on polyuria in V2RA-treated ADPKD patients.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

主要终点24小时尿量在低盐低蛋白期从基线5.9±1.2 L降至5.2±1.1 L(-11%,P=.004),低盐期降至5.4±0.9 L(-8%,P=.04)。降低膳食盐和蛋白摄入对尿量影响较小,但可降低copeptin浓度。

要点

  • 低盐低蛋白饮食使V2RA治疗的ADPKD患者24小时尿量从基线5.9±1.2 L降至5.2±1.1 L(-11%,P=.004)。
  • 低盐饮食使24小时尿量降至5.4±0.9 L(-8%,P=.04),降幅小于低盐低蛋白。
  • 尿渗透压较低的患者24小时尿量降幅更大(-16% vs -7%)。

核心结论

  • 降低膳食盐和蛋白摄入对V2RA治疗的ADPKD患者尿量影响较小。
  • 减少渗透质摄入可降低copeptin浓度,可能增强V2RA在ADPKD患者中的肾脏保护作用。

研究设计与样本

  • 患者在低盐低蛋白饮食基础上补充盐和蛋白模拟常规摄入,随后以安慰剂替代,随机顺序进行四个2周周期。

主要发现

  • 基线盐和蛋白摄入分别为10.8±1.3 g/24-h和1.2±0.2 g/kg/24-h,低盐低蛋白期降至5.8±1.6 g/24-h和0.8±0.1 g/kg/24-h。
  • 基线24小时尿量5.9±1.2 L,低盐低蛋白期降至5.2±1.1 L(-11%,P=.004),低盐期降至5.4±0.9 L(-8%,P=.04)。
  • 尿渗透压较低的患者24小时尿量降幅为-16%,尿渗透压较高的患者为-7%。
  • 多尿生活质量评分随尿量变化同步改善;低盐低蛋白期mGFR下降,平均动脉压在各研究期无变化;低盐低蛋白期血浆copeptin显著下降。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The only treatment proven to be renoprotective in autosomal dominant polycystic kidney disease (ADPKD) is a vasopressin V2-receptor antagonist (V2RA). However, aquaresis-associated side effects limit tolerability. We investigated whether salt and/or protein intake influences urine volume and related endpoints in V2RA-treated ADPKD patients. METHODS: In this randomized, controlled, double-blind, crossover trial, ADPKD patients treated with maximally tolerated dose of a V2RA were included. While on a low salt and low protein diet, patients were given additional salt and protein to mimic regular intake, which was subsequently replaced by placebo in random order during four 2-week periods. Primary endpoint was change in 24-h urine volume. Secondary endpoints were change in quality of life, measured glomerular filtration rate (mGFR), blood pressure and copeptin level. RESULTS: Twelve patients (49 ± 8 years, 25.0% male) were included. Baseline salt and protein intake were 10.8 ± 1.3 g/24-h and 1.2 ± 0.2 g/kg/24-h, respectively. During the low salt and low protein treatment periods, intake decreased to 5.8 ± 1.6 g/24-h and 0.8 ± 0.1 g/kg/24-h, respectively. Baseline 24-h urine volume (5.9 ± 1.2 L) decreased to 5.2 ± 1.1 L (-11%, P = .004) on low salt and low protein, and to 5.4 ± 0.9 L (-8%, P = .04) on low salt. Reduction in 24-h urine volume was two times greater in patients with lower urine osmolality (-16% vs -7%). Polyuria quality of life scores improved in concordance with changes in urine volume. mGFR decreased during the low salt and low protein, while mean arterial pressure did not change during study periods. Plasma copeptin decreased significantly during low salt and low protein periods. CONCLUSION: Lowering dietary salt and protein intake has a minor effect on urine volume in V2RA-treated ADPKD patients. Reduced intake of osmoles decreased copeptin concentrations and might thus increase the renoprotective effect of a V2RA in ADPKD patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Geertsema P, Koorevaar IW, Ipema KJR, et al. Effects of salt and protein intake on polyuria in V2RA-treated ADPKD patients. Nephrol Dial Transplant. 2024. PMID: 37804179. doi:10.1093/ndt/gfad218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。